{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T12:26:39Z","timestamp":1791894399318,"version":"4.3.4"},"reference-count":18,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2013,2,1]],"date-time":"2013-02-01T00:00:00Z","timestamp":1359676800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2013,2,1]],"date-time":"2013-02-01T00:00:00Z","timestamp":1359676800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2013,7,22]],"date-time":"2013-07-22T00:00:00Z","timestamp":1374451200000},"content-version":"vor","delay-in-days":171,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/3.0\/"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation","doi-asserted-by":"crossref","award":["30973587"],"award-info":[{"award-number":["30973587"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100002858","name":"China Postdoctoral Science Foundation","doi-asserted-by":"crossref","award":["20110491328"],"award-info":[{"award-number":["20110491328"]}],"id":[{"id":"10.13039\/501100002858","id-type":"DOI","asserted-by":"crossref"}]},{"name":"National Natural Science Funds for Young Scholar","award":["81102383"],"award-info":[{"award-number":["81102383"]}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Pharmaceutical Analysis"],"published-print":{"date-parts":[[2013,2]]},"DOI":"10.1016\/j.jpha.2012.10.006","type":"journal-article","created":{"date-parts":[[2012,11,7]],"date-time":"2012-11-07T19:32:24Z","timestamp":1352316744000},"page":"1-8","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":11,"title":["Quantitation of bivalirudin, a novel anticoagulant peptide, in human plasma by LC\u2013MS\/MS: Method development, validation and application to pharmacokinetics"],"prefix":"10.1016","volume":"3","author":[{"given":"Xiao-Jiao","family":"Li","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yan-Tong","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lei","family":"Yin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xue-Ju","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yan","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.","family":"Paul Fawcett","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yi-Min","family":"Cui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing-Kai","family":"Gu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jpha.2012.10.006_bib1","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/j.beha.2004.02.002","article-title":"Bivalent direct thrombin inhibitors: hirudin and bivalirudin","volume":"17","author":"Warkentin","year":"2004","journal-title":"Best Pract. Res. Clin. Haematol."},{"key":"10.1016\/j.jpha.2012.10.006_bib2","doi-asserted-by":"crossref","first-page":"357","DOI":"10.2147\/vhrm.2006.2.4.357","article-title":"Bivalirudin in percutaneous coronary intervention","volume":"2","author":"Lehman","year":"2006","journal-title":"J. Vasc. Health Risk Manage."},{"key":"10.1016\/j.jpha.2012.10.006_bib3","doi-asserted-by":"crossref","first-page":"1047","DOI":"10.1016\/j.amjcard.2004.06.065","article-title":"Bivalirudin versus heparin as an antithrombotic agent in patients treated with a sirolimus-eluting stent","volume":"94","author":"Rha","year":"2004","journal-title":"Am. J. Cardiol."},{"key":"10.1016\/j.jpha.2012.10.006_bib4","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/S0149-2918(02)85004-4","article-title":"Bivalirudin: a direct thrombin inhibitor","volume":"24","author":"Gladwell","year":"2002","journal-title":"Clin. Ther."},{"key":"10.1016\/j.jpha.2012.10.006_bib5","doi-asserted-by":"crossref","first-page":"716","DOI":"10.1016\/j.amjcard.2004.11.021","article-title":"Effectiveness and safety of bivalirudin during percutaneous coronary intervention in a single medical center","volume":"95","author":"Gurm","year":"2005","journal-title":"Am. J. Cardiol."},{"key":"10.1016\/j.jpha.2012.10.006_bib6","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1016\/j.amjcard.2003.10.021","article-title":"Effectiveness of bivalirudin as a replacement for heparin during cardiopulmonary bypass in patients undergoing coronary artery bypass grafting","volume":"93","author":"Koster","year":"2004","journal-title":"Am. J. Cardiol."},{"key":"10.1016\/j.jpha.2012.10.006_bib7","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1016\/j.jchromb.2003.12.003","article-title":"Liquid chromatography method for determination of bivalirudin in human plasma and urine using automated ortho-phthalaldehyde derivatization and fluorescence detection","volume":"802","author":"Farthing","year":"2004","journal-title":"J. Chromatogr. B"},{"key":"10.1016\/j.jpha.2012.10.006_bib8","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1067\/mcp.2002.124522","article-title":"Bivalirudin pharmacokinetics and pharmacodynamics: effect of renal function, dose, and gender","volume":"71","author":"Robson","year":"2002","journal-title":"Clin. Pharmacol. Ther."},{"key":"10.1016\/j.jpha.2012.10.006_bib9","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/j.jpba.2009.12.002","article-title":"Development and validation of a LC\u2013MS\/MS method for determination of bivalirudin in human plasma: application to a clinical pharmacokinetic study","volume":"52","author":"Pan","year":"2010","journal-title":"J. Pharm. Biomed. Anal."},{"key":"10.1016\/j.jpha.2012.10.006_bib10","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1007\/s00216-003-2298-y","article-title":"Analytical procedures for quantification of peptides in pharmaceutical research by liquid chromatography\u2013mass spectrometry","volume":"378","author":"John","year":"2004","journal-title":"Anal. Bioanal. Chem"},{"key":"10.1016\/j.jpha.2012.10.006_bib11","unstructured":"Guidance for Industry: Bioanalytical Method Validation, Food and Drug Administration, USA, 2001."},{"key":"10.1016\/j.jpha.2012.10.006_bib12","unstructured":"ICH Harmonised Tripartite Guideline, Guideline for Good Clinical Practice, 1996."},{"key":"10.1016\/j.jpha.2012.10.006_bib13","first-page":"514","article-title":"TopFit: a PC-based pharmacokinetic\/pharmacodynamic data analysis program","volume":"31","author":"Tanswell","year":"1993","journal-title":"Int. J. Clin. Pharmacol. Ther. Toxicol."},{"key":"10.1016\/j.jpha.2012.10.006_bib14","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1016\/j.jpha.2012.01.008","article-title":"Quantification of desloratadine in humanplasma by LC\u2013ESI-MS\/MS and application to a pharmacokinetic study","volume":"2","author":"Ponnurua","year":"2012","journal-title":"J. Pharm. Anal."},{"key":"10.1016\/j.jpha.2012.10.006_bib15","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/S0378-4347(01)00342-5","article-title":"Determination of metformin in human plasma by high-performance liquid chromatography with spectrophotometric detection","volume":"762","author":"Cheng","year":"2001","journal-title":"J. Chromatogr. B Biomed. Sci. Appl"},{"key":"10.1016\/j.jpha.2012.10.006_bib16","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/j.jchromb.2004.05.006","article-title":"Rapid and sensitive liquid chromatography\u2013tandem mass spectrometric method for the quantitation of metformin in human plasma","volume":"808","author":"Wang","year":"2004","journal-title":"J. Chromatogr. B"},{"key":"10.1016\/j.jpha.2012.10.006_bib17","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1002\/rcm.2822","article-title":"Determination of miglitol in human plasma by liquid chromatography\/tandem mass spectrometry","volume":"21","author":"Li","year":"2007","journal-title":"Rapid Commun. Mass Spectrom"},{"key":"10.1016\/j.jpha.2012.10.006_bib18","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1213\/01.ane.0000226098.95698.0f","article-title":"Bivalirudin provides rapid, effective, and reliable anticoagulation during off pump coronary revascularization: results of the \u201cEVOLUTION OFF\u201d trial","volume":"103","author":"Koster","year":"2006","journal-title":"Anesth. Analg."}],"container-title":["Journal of Pharmaceutical Analysis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2095177912001220?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2095177912001220?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,30]],"date-time":"2025-10-30T21:26:40Z","timestamp":1761859600000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2095177912001220"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,2]]},"references-count":18,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2013,2]]}},"alternative-id":["S2095177912001220"],"URL":"https:\/\/doi.org\/10.1016\/j.jpha.2012.10.006","relation":{},"ISSN":["2095-1779"],"issn-type":[{"value":"2095-1779","type":"print"}],"subject":[],"published":{"date-parts":[[2013,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Quantitation of bivalirudin, a novel anticoagulant peptide, in human plasma by LC\u2013MS\/MS: Method development, validation and application to pharmacokinetics","name":"articletitle","label":"Article Title"},{"value":"Journal of Pharmaceutical Analysis","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jpha.2012.10.006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2013 Xi'an Jiaotong University. Production and hosting by Elsevier B.V.","name":"copyright","label":"Copyright"}]}}